Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vaxgen Inc (VXGN) since 2011 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vaxgen Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1036968.
Total stock buying since 2011: $87,221.
Total stock sales since 2011: $42,358.
Total stock option exercises since 2011: $68,900.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2014 | 0 | $0 | 0 | $0 | 2,108 | $590 |
| 2013 | 0 | $0 | 0 | $0 | 67,461 | $18,440 |
| 2012 | 0 | $0 | 198,140 | $42,358 | 179,121 | $49,870 |
| 2011 | 219,087 | $87,221 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2014-04 | 0 | $0 | 0 | $0 | 2,108 | $590 |
| 2013-12 | 0 | $0 | 0 | $0 | 20,000 | $5,800 |
| 2013-09 | 0 | $0 | 0 | $0 | 42,421 | $11,029 |
| 2013-03 | 0 | $0 | 0 | $0 | 5,040 | $1,611 |
| 2012-12 | 0 | $0 | 0 | $0 | 69,121 | $17,971 |
| 2012-08 | 0 | $0 | 0 | $0 | 110,000 | $31,899 |
| 2012-01 | 0 | $0 | 198,140 | $42,358 | 0 | $0 |
| 2011-02 | 50,587 | $20,081 | 0 | $0 | 0 | $0 |
| 2011-01 | 168,500 | $67,140 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-04-28 | Viret Jean-frederic (Chief Financial Officer) | Option Ex | 2,108 | .28 | 590 |
| 2013-12-04 | Zychlinsky Bulaevsky Emilia (Chief Technical Officer) | Option Ex | 20,000 | .29 | 5,800 |
| 2013-09-03 | Richey Robert Michael (Chief Business Officer) | Option Ex | 42,421 | .26 | 11,029 |
| 2013-03-27 | Zychlinsky Bulaevsky Emilia (Chief Technical Officer) | Option Ex | 2,500 | .36 | 900 |
| 2013-03-27 | Viret Jean-frederic (Chief Financial Officer) | Option Ex | 2,540 | .28 | 711 |
| 2012-12-12 | Richey Robert Michael (Chief Business Officer) | Option Ex | 69,121 | .26 | 17,971 |
| 2012-08-31 | Ward Brian E. (President and CEO) | Option Ex | 110,000 | .29 | 31,899 |
| 2012-01-27 | Baker Julian (10% Owner) | Sale | 59,340 | .22 | 13,173 |
| 2012-01-19 | Baker Julian (10% Owner) | Sale | 20,000 | .20 | 4,000 |
| 2012-01-18 | Baker Julian (10% Owner) | Sale | 118,800 | .21 | 25,185 |
| 2011-02-07 | Burrill Steven (10% Owner) | Buy | 5,000 | .40 | 2,000 |
| 2011-02-03 | Burrill Steven (10% Owner) | Buy | 15,287 | .40 | 6,114 |
| 2011-02-02 | Burrill Steven (10% Owner) | Buy | 15,000 | .40 | 6,000 |
| 2011-02-01 | Burrill Steven (10% Owner) | Buy | 15,300 | .39 | 5,967 |
| 2011-01-28 | Burrill Steven (10% Owner) | Buy | 13,000 | .38 | 4,940 |
| 2011-01-24 | Burrill Steven (10% Owner) | Buy | 100,000 | .40 | 40,000 |
| 2011-01-21 | Burrill Steven (10% Owner) | Buy | 55,500 | .40 | 22,200 |
Insider trading activities including stock purchases, stock sales, and option exercises of VXGN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vaxgen Inc (symbol VXGN, CIK number 1036968) see the Securities and Exchange Commission (SEC) website.